XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity
9 Months Ended
Sep. 30, 2022
Stockholders' Equity  
Stockholders' Equity

8.Stockholders’ Equity

Preferred Stock

Under the Company’s Restated Certificate of Incorporation, the Company has 5,000,000 shares of preferred stock authorized for issuance, with a $0.001 par value per share. Preferred stock may be issued from time to time in one or more series, each series to have such terms as stated or expressed in the resolutions providing for the issue of such series adopted by the Board of Directors of the Company. Preferred stock which may be redeemed, purchased or acquired by the Company may be reissued except as otherwise provided by law. As of September 30, 2022, the Company had 31,455 shares of Series X Preferred Stock outstanding. Each share of Series X Preferred Stock is convertible into 166.67 shares of common stock and therefore the number of shares of underlying common stock issuable upon conversion of the Series X Preferred Stock is 5,242,501. Refer to Note 1, “Organization and Operations” regarding the Company’s issuance of Series X Preferred Stock in January 2021 and February 2021.

Outstanding Warrants

The following table presents information about warrants that are issued and outstanding at September 30, 2022:

Year Issued

    

Equity Instrument

    

Warrants Outstanding

    

Exercise Price

    

Date of Expiration

2018

 

Common Stock

699,962

$

72.00

 

6/21/2023

2019

 

Common Stock

331,858

$

37.50

 

2/7/2024

2021

Common Stock

498,356

$

2.10

12/14/2030

Total

 

1,530,176

 

 

Weighted average exercise price

$

41.75

 

Weighted average life in years

 

  

 

3.30